BSE: NATCOPHARM - NATCO Pharma Limited

半年間の収益性: -50.48%
配当利回り: +0.75%

プロモーションスケジュール NATCO Pharma Limited

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.

さらに詳しく
The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

ISIN INE987B01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.9395
Дивиденд ао 6
Сайт https://www.natcopharma.co.in
Цена ао 780.8
1日あたりの価格変動: +0.0192% (780.8)
週ごとの価格変動: -5.35% (825.05)
月ごとの料金変更: -35.81% (1216.65)
3ヶ月間の価格変動: -45.83% (1441.75)
半年間の価格変動: -50.48% (1577)
年間の価格変動: -20.18% (978.35)
3年間の価格推移: -7.48% (844.1)
5年間の価格推移: +23.02% (634.8)
10年間の価格推移: 0% (780.95)
年初からの価格変動: -44.11% (1397.3)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 4.28 4
P/BV 2.91 6
P/E 12.27 8
EV/EBITDA 9.66 8
合計: 7.38

効率

名前 意味 学年
ROA, % 22.1 7
ROE, % 25.88 8
合計: 6

配当金

名前 意味 学年
Div yield, % 0.7538 1.88
DSI 0.8571 8.57
合計: 2.83

義務

名前 意味 学年
Debt/EBITDA 0.1605 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 110.76 10
収益性 Ebitda, % 12.83 2
収益性 EPS, % 206.73 10
合計: 8.4
さらに詳しく

スーパーバイザー 役職 支払い 生年
Mr. Rajeev Nannapaneni CEO & Vice Chairman N/A 1977 (48 年)
Mr. S. V. V. N. Appa Rao Chief Financial Officer N/A
Dr. Donthineni Linga Rao M.D. President of Technical Affairs & Whole Time Director N/A 1952 (73 年)
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Chairman N/A 1945 (80 年)
Mr. Potluri Sivaramakrishna Prasad Executive VP of Corporate Engineering Services & Whole Time Director N/A 1958 (67 年)
Mr. Chekuri Venkat Ramesh C.S. Company Secretary & Compliance Officer 3M
Dr. Pavan Ganapati Bhat Executive VP of Technical Operations & Director N/A 1967 (58 年)
N. Sadasiva Rao Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management N/A
James Rajakumar Vice President of Marketing & Sales - Domestic N/A
Nadella Malleswara Rao VP & Head of Operations

住所: India, Hyderabad, Natco House - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.natcopharma.co.in